Pfizer Will Sell German Drug Plant | Chemical & Engineering News
Volume 85 Issue 12 | p. 17 | Concentrates
Issue Date: March 19, 2007

Pfizer Will Sell German Drug Plant

Department: Business

Pfizer CentreSource (PCS), the contract manufacturing division of Pfizer, says its Heumann PCS business will be sold as part of Pfizer's previously announced plan to divest its Feucht, Germany, manufacturing site. Michael J. Kosko, president of PCS, says Heumann produces specialty pharmaceutical chemicals such as high-containment and high-potency compounds. "The planned sale does not impact the fine chemicals and contract manufacturing business units, which focus on steroids and drug products, respectively," Kosko says.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment